SCOPUS 정보 검색 플랫폼

British Journal of Clinical Pharmacology

Volumn 72, Issue 5, 2011, Pages 839-841

QT interval shortening in spontaneous reports submitted to the FDA: The need for consensus

(5) Raschi, Emanuel a Poluzzi, Elisabetta a Koci, Ariola a Boriani, Giuseppe b De Ponti, Fabrizio a

a UNIVERSITY OF BOLOGNA (Italy)

b UNIVERSITY OF BOLOGNA (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ARIPIPRAZOLE; ARSENIC TRIOXIDE; ATENOLOL; ATOMOXETINE; BEVACIZUMAB; CAPECITABINE; CARBAMAZEPINE; CEFTRIAXONE; CLARITHROMYCIN; CLOZAPINE; COTRIMOXAZOLE; DACARBAZINE; DIGOXIN; DOXORUBICIN; IFOSFAMIDE; IMIPRAMINE; MELPHALAN; MESNA; MOXIFLOXACIN; NATALIZUMAB; PARACETAMOL; PAROXETINE; QUETIAPINE; RUFINAMIDE; SUNITINIB; TELITHROMYCIN; THALIDOMIDE; UNINDEXED DRUG; ZIPRASIDONE;

ARRHYTHMOGENESIS; CARDIOTOXICITY; CONSENSUS; DISEASE ASSOCIATION; DISEASE MARKER; FOOD AND DRUG ADMINISTRATION; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; HUMAN; LENNOX GASTAUT SYNDROME; LETTER; PRIORITY JOURNAL; QT PROLONGATION; SHORT QT INTERVAL; SUDDEN DEATH; TORSADE DES POINTES;

ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80053900545 PISSN: 03065251 EISSN: 13652125 Source Type: Journal
DOI: 10.1111/j.1365-2125.2011.04065.x Document Type: Letter

Times cited : (8)

References (5)

1
- 78650122732
- Drug-induced long QT syndrome
- Kannankeril P, Roden DM, Darbar D. Drug-induced long QT syndrome. Pharmacol Rev 2010; 62: 760-81.
- (2010) Pharmacol Rev , vol.62 , pp. 760-781
- Kannankeril, P.¹ Roden, D.M.² Darbar, D.³

2
- 20344369318
- Short QT syndrome: mechanisms, diagnosis and treatment
- Bjerregaard PF, Gussak I. Short QT syndrome: mechanisms, diagnosis and treatment. Nat Clin Pract Cardiovasc Med 2005; 2: 84-7.
- (2005) Nat Clin Pract Cardiovasc Med , vol.2 , pp. 84-87
- Bjerregaard, P.F.¹ Gussak, I.²

3
- 58149475094
- Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development?
- Holbrook M, Malik M, Shah RR, Valentin JP. Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development? J Pharmacol Toxicol Methods 2009; 59: 21-8.
- (2009) J Pharmacol Toxicol Methods , vol.59 , pp. 21-28
- Holbrook, M.¹ Malik, M.² Shah, R.R.³ Valentin, J.P.⁴

4
- 58149109205
- Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period
- Raschi E, Poluzzi E, Zuliani C, Muller A, Goossens H, De Ponti F. Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period. Br J Clin Pharmacol 2009; 67: 88-98.
- (2009) Br J Clin Pharmacol , vol.67 , pp. 88-98
- Raschi, E.¹ Poluzzi, E.² Zuliani, C.³ Muller, A.⁴ Goossens, H.⁵ De Ponti, F.⁶

5
- 74549126556
- Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives
- Shah RR. Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives. Br J Pharmacol 2010; 159: 58-69.
- (2010) Br J Pharmacol , vol.159 , pp. 58-69
- Shah, R.R.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.